Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.
about
Rodent Hypoxia-Ischemia Models for Cerebral Palsy Research: A Systematic ReviewNeuroprotective Strategies after Neonatal Hypoxic Ischemic EncephalopathyMechanisms of perinatal arterial ischemic strokeTopiramate treatment is neuroprotective and reduces oligodendrocyte loss after cervical spinal cord injuryGlutamate receptor ion channels: structure, regulation, and functionAMPA-Kainate Receptor Inhibition Promotes Neurologic Recovery in Premature Rabbits with Intraventricular HemorrhageMaternal omega-3 fatty acid supplementation protects against lipopolysaccharide-induced white matter injury in the neonatal rat brainOligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia.Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI)Pathophysiology of glia in perinatal white matter injury.CSAX: Characterizing Systematic Anomalies in eXpression Data.Neuroimaging in cerebral palsy: Patterns of brain dysgenesis and injury.Progress in periventricular leukomalacia.NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.Comparative analysis of the beneficial effects of treadmill training and electroacupuncture in a rat model of neonatal hypoxia-ischemiaSynergistic neuroprotective therapies with hypothermia.Timing of appearance of late oligodendrocyte progenitors coincides with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia-ischemia.The challenge of understanding cerebral white matter injury in the premature infant.Hypoxic ischemic brain injury: Potential therapeutic interventions for the future.The immune response after hypoxia-ischemia in a mouse model of preterm brain injury.Protective Effects of Berberine on Oxygen-Glucose Deprivation/Reperfusion on Oligodendrocyte Cell Line (OLN-93).Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. II. Human cerebral white matter and cortex.Altered glutamatergic metabolism associated with punctate white matter lesions in preterm infantsTalampanel suppresses the acute and chronic effects of seizures in a rodent neonatal seizure model.The developing oligodendrocyte: key cellular target in brain injury in the premature infantDevelopmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brainHyperoxia causes maturation-dependent cell death in the developing white matter.Developmental regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor subunit expression in forebrain and relationship to regional susceptibility to hypoxic/ischemic injury. I. Rodent cerebral white matter and cortex.Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalaciaOxidative stress disrupts oligodendrocyte maturation.Mouse models of periventricular leukomalaciaCell replacement therapy in neurological disease.Axon-glia synapses are highly vulnerable to white matter injury in the developing brainSystemic prenatal insults disrupt telencephalon development: implications for potential interventions.Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human.Glia Disease and Repair-RemyelinationRoles of white matter in central nervous system pathophysiologies.Oligodendrocytes Are Targets of HIV-1 Tat: NMDA and AMPA Receptor-Mediated Effects on Survival and Development.Progenitor cell-based treatment of the pediatric myelin disordersRole of glutamate receptors in periventricular leukomalacia.
P2860
Q26747485-7DA43EB9-1B7A-41F6-89AB-247C9B997D1DQ26782756-B16BF6CF-2ECB-44BD-9D90-6EA60CA68A03Q26998918-C94F5623-B4FF-4341-BC24-06378FA8C23EQ27306821-A01B1610-83F4-44E0-A18F-E845E9AA3676Q28290774-6EBD111D-334E-4BEA-8FE9-0CB1BE8EA953Q28389765-04559C74-1529-4592-99BC-71DEB5623351Q28567546-DB618DEC-6B79-4E49-B5D9-D7433C62557AQ30405077-8FAF7A23-95B2-4FD0-AC8E-68697EECC216Q30462209-7983E9EB-28A7-4691-AD35-F0A4DF5E0F5DQ30790294-1441861D-7F20-4248-8A97-A4C7CA332A4EQ30887501-56768484-7DC1-491E-9724-4D62BD53A571Q33231806-F5175B71-D613-4056-93CD-C572C3710676Q33375579-62220C00-9C1A-45B4-853F-2FFF7AAB5D88Q33565598-45527B90-CBC6-4B1A-91B9-9C42276F72F6Q33674966-51386A5F-E12C-48F2-B9FC-EBD250A0E7CCQ33943360-01DE99C2-4EDA-4FBC-B54D-7CA091735D4DQ34042991-FF66987F-F986-4D59-A90D-25539B911D17Q34098352-E3B33E77-134B-461D-A42E-DE6400A02B5AQ34106605-5A83DF11-5B43-47B7-B090-C14382A3F0E4Q34233973-DED2D0B8-5969-4800-949A-AAF18FC81842Q34318643-29C75135-DB55-42DD-A34D-37EF10C8CF4AQ34330653-C944CF56-C29C-49DE-B50D-3851E1786EFEQ34611606-D15E4B85-EDF9-41C1-AD4F-6C6B9950A7A7Q34946029-D01B8235-5869-4DB5-B6EF-B75C2E970A32Q34995998-631B2DB6-F9B6-4DB7-89C6-42DF4493C1F4Q35003575-7E068CF2-666F-4DD7-BFF1-C3A960328DB2Q35009330-A1F655E1-8780-4613-9F2F-4EBF841D174CQ35037490-9D59DB6F-D816-4B36-919D-9A2FB657E2E3Q35042888-44512444-04A6-43B8-9015-2F7540173B9CQ35111405-FD579F72-62AF-44A1-AC61-9237091DE707Q35146798-AF3018C0-C28B-44FA-8E1E-77B626A7BD63Q35172117-587DB052-9A25-4F49-91A7-EA782BC87473Q35531951-6CEA5467-2AE0-425D-B6CA-E24DC5027D22Q35569038-6B5DF16C-4E61-451C-9191-E8060C0FD4B7Q35576382-1CCB9026-A882-427B-988A-C516139C5279Q35795587-972BFC8F-72BD-4214-99E6-3150CF4B0DF1Q35846494-A650D6A9-03CD-4878-9BA9-897835AA03A2Q35941437-B6C5076D-BDDC-4CCD-83F3-61CE3977087DQ35983132-6F2D1BA7-EC20-434A-B1E5-36CCB4CF64FCQ36370763-E29B4DC4-CF05-470A-8872-683E620C9E3E
P2860
Glutamate receptor-mediated oligodendrocyte toxicity in periventricular leukomalacia: a protective role for topiramate.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Glutamate receptor-mediated ol ...... rotective role for topiramate.
@ast
Glutamate receptor-mediated ol ...... rotective role for topiramate.
@en
Glutamate receptor-mediated ol ...... rotective role for topiramate.
@nl
type
label
Glutamate receptor-mediated ol ...... rotective role for topiramate.
@ast
Glutamate receptor-mediated ol ...... rotective role for topiramate.
@en
Glutamate receptor-mediated ol ...... rotective role for topiramate.
@nl
prefLabel
Glutamate receptor-mediated ol ...... rotective role for topiramate.
@ast
Glutamate receptor-mediated ol ...... rotective role for topiramate.
@en
Glutamate receptor-mediated ol ...... rotective role for topiramate.
@nl
P2093
P1476
Glutamate receptor-mediated ol ...... protective role for topiramate
@en
P2093
Delia M Talos
Frances E Jensen
Joseph J Volpe
Leon J Massillon
Pamela L Follett
Weimin Dai
Wenbin Deng
P304
P356
10.1523/JNEUROSCI.0477-04.2004
P407
P577
2004-05-01T00:00:00Z